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signiﬁcant results were found in the two groups. Signiﬁcantly lower muscle strength 
was observed in case of nulliparous women (n  18) who have experienced vaginal 
wall laxity (p  0.004) and in pregnant women. (p  0.0008) Duration of PFM con-
traction was signiﬁcantly worse in pregnant women (p  0.001). Women who occa-
sionally do some forms of physical activity showed a signiﬁcantly better muscle 
strength (p  0.029), and women who regularly do some physical exercise showed a 
signiﬁcantly longer duration of maximum contraction (p  0.018) than pregnant 
women doing occasional or regular exercise. Comparing only the results of pregnant 
women we found a signiﬁcant difference in PFM strength of women doing occasional 
and regular exercise and almost signiﬁcant results were found in women who never 
or occasionally do exercises. CONCLUSIONS: A signiﬁcantly decreased maximum 
pelvic ﬂoor muscle strength and duration of maximum contraction could be observed 
in pregnancy compared to nulliparous young women doing regular or occasional 
physical exercise and experiencing vaginal wall laxity.
PIH5
EXAMINATION OF GAIT DURING THE TRIMESTERS OF PREGNANCY
Hock M, Dálnoki É, Dakos Z, Kriszbacher I, Boncz I, Kránicz J, Bódis J
University of Pécs, Pécs, Hungary
OBJECTIVES: Our aim was to prove the effects of physiological changes during 
pregnancy on gait as a manifestation of dynamic posture. METHODS: Our prospec-
tive non-random study was performed at the Department of Obstetrics and Gynaecol-
ogy, Medical School, University of Pécs between 2008–2009 involving forty-two 
women: twenty-one were in the ﬁrst, second and third trimesters and twenty-one were 
non pregnant (control group). Exclusion criteria included: pathological pregnancy, 
severe musculoskeletal, internal and neurological diseases. Allocation of patients was 
non randomized. MS Excel 2003 software was used for evaluation, data processing 
of stabilometric measurement results and Questionnaires. Measurement of parameters 
was performed by stabilometer. Statistical data were calculated according to mean, 
standard deviation, T-test methods and the results were considered to be relevant at 
p  0.05. RESULTS: The gait of pregnant women proved to be slower than that of 
the control group (p  0.046), but the duration of step-cycle decreased during the 
course of pregnancy. The duration of swing phase in the ﬁrst trimester is shorter 
compared to the control group (p  0.040). The rate of double-limb support to the 
total step-cycle showed an increase (p  0.023) when comparing the third trimester 
with the control group. On examination of foot roll-over a signiﬁcant difference was 
found (p  0.006) when comparing to the ﬁrst trimester. The foot angle of pregnant 
women in the ﬁrst trimester was bigger than that of the control group (p  0.029). 
Pregnant women’s step width in the ﬁrst trimester was smaller as compared to the 
control group (p  0.002). Comparing step width of pregnant women in the ﬁrst and 
third trimesters a signiﬁcant increase was revealed (p  0.049). CONCLUSIONS: Our 
study revealed that gait kinematics changed during pregnancy and showed a difference 
as compared to the control group.
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CHANGES OF HEART RATE VARIABILITY AFTER SHORT-TERM 
MEDITATION TRAINING IN COLLEGE STUDENT
Chung JH, Kim SH
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OBJECTIVES: Many clinical studies have shown that meditation have positive effects 
in anxiety disorders, depression, cardiovascular diseases. But types of meditation 
which had been used in the past studies were complex and long-term training pro-
grams. In this pilot study, we investigate changes of heart rate variability after short-
term MBSR(mindfulness based stress reduction) respiratory meditation to understand 
its effects on autonomic nervous system. METHODS: METHODS We evaluated 34 
healthy college students aged 25 to 35 from June 2008 to August 2008. All the subjects 
gave their informed consent, and the study was approved by Institutional Review 
Board of the Korean Society of Complementary and Alternative Medicine. The medita-
tion program adopted here was a MBSR respiratory meditation. We surveyed infor-
mations concerning the past history, the amount of exercise by means of the 
self-questionnaire records and heart rate variability was measured to investigate the 
physiologic phenomena related with autonomic functions. RESULTS: There was no 
signiﬁcant relationship between the stress response inventory and the changes of heart 
rate variability. The changes of the mean value of SDNN(The Standard deviation of 
Normal to Normal intervals), RMSSD(Square root of the mean of the sum of the 
square of differences between adjacent NN intervals), total power, entropy and LF(low 
frequency) were not signiﬁcant. However, the mean value of RMSSD(Square root of 
the mean of the sum of the square of differences between adjacent NN intervals) were 
signiﬁcantly decreased after meditation(P  0.000). The decrease in systolic and dia-
stolic blood pressure werealso observed after meditation(P  0.05). CONCLUSIONS: 
This results indicate that the meditation is positively correlated with the heart rate 
variability and parasympathetic nervous system can be intensiﬁed by the short-term 
MBSR meditation program.
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OBJECTIVES: Many international literatures have evaluated the quality of health care 
of patients hospitalized on different days of the week, during non-ofﬁce hours and at 
night. The time of admission can usually not be chosen by the patient in two wards: 
in the Intensive Care Unit (ICU) and the maternity ward. The aim was to examine 
whether the time of admission had any inﬂuence on the mortality in Hungary. 
METHODS: The ﬁgures of the ICUs and the maternity wards were evaluated between 
2000 and 2008. Data were derived from the ﬁnancial database of the National Health 
Insurance Fund Administration, the only health care ﬁnancing agency in Hungary. 
RESULTS: Mortality of 15.3% of patients admitted to the ICU on Monday decreases 
to 12.5% of those admitted on Friday, then increases to 20.3% on Saturday and 
25.3% on Sunday. On the other hand neonatal mortality above 2500 gms is between 
0.09% and 0.11% during the week. It is 0.1% on Saturday and 0.11% on Sunday. 
Examining the admissions by the hours of the day, in the ICU the potential to survive 
is the highest with patients being admitted at the beginning of ofﬁce-hours, at 8 
o’clock, with 6.6%. After that mortality is continuously increasing until reaching its 
peak of 22.6% at 2 o’clock in the morning. Results can be explained by saying, 
employees have the least working capacity or patients being admitted to the ICU at 
night hours are in severe condition having less chance to survive. CONCLUSIONS: 
The health care on the weekend and night differs in quality from the rest of the week 
and the day. Whether it is due to schooling or the number of staff needs further evalu-
ation. These data conﬁrm that quality of health care of different wards can also be 
characterized by the mortality depending on the time of admission.
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OBJECTIVES: To evaluate the budget impact to a health plan after introducing 
dienogest (2 mg) as a treatment option for endometriosis-associated pelvic pain (EAPP) 
patients. METHODS: The analysis was conducted from a German payer’s perspective 
over a ﬁve-year time horizon. The budget impact model (BIM) speciﬁcally considered 
women with EAPP. This included women with newly diagnosed endometriosis and 
women who have previously failed other medical treatment for EAPP. A recently 
developed cost-effectiveness (CE) model for endometriosis provided the estimates of 
average treatment duration. This CE model compared different treatment pathways 
for women with EAPP and used a 50% improvement in pelvic pain as a deﬁnition of 
a treatment responder to elicit treatment duration. After combining epidemiological 
data, market uptake assumptions from market research forecasting, and current 
GnRH-a drug treatment costs, and average treatment duration, the BIM estimated the 
incremental budget impact after adopting dienogest as a treatment option at the 
expense of GnRH-analogues. The model assumed that during the ﬁrst year, 5% of 
EAPP patients receive dienogest at the expense of GnRH-analogues. After 5 years, it 
was assumed that dienogest would capture 15% of the EAPP market. A plausible 
range of parameter values were considered in the sensitivity analysis. RESULTS: In 
the hypothetical health plan approximately 0.54% of members were estimated to be 
diagnosed with EAPP and receiving medical intervention. In the year after introduction 
of dienogest, the overall budget used to treat EAPP was estimated to decrease by up 
to 4% with the budget saving estimated to increase to around 11.0% by Year 5. 
CONCLUSIONS: In patients with EAPP, the budgetary impact of adding dienogest 
to a health plan, in Germany, at the expense of the GnRH-analogues was estimated 
to result in a budgetary cost saving.
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OBJECTIVES: An observational study was performed to determine the prevalence 
and economic burden for 3 stages of menopause: pre-menopause, perimenopause and 
post-menopause. METHODS: A prospective, primary care practice based, multicenter, 
observational study was conducted in Canada to determine the prevalence and burden 
for each stage of menopause as listed above. Women age 48–54 were asked to recall 
their expenses of the past 6 months for physician visits (general practitioners and 
specialists), hospital ward and emergency room (ER), pharmacotherapy and produc-
tivity loss (absenteeism, or missed work, and presenteeism or work with reduced 
productivity). Resource utilisation was costed as per standard costing sources in 
Canadian dollars (CAD$). Sample size calculations were done with a conﬁdence level 
of 95% and power of 80%, allowing for 10% precision with 3% drop-out rate. Sta-
tistical analyses were performed on demographics, prevalence rates and the total costs 
for each stage and overall. Results were compared using Kriskal-Wallis tests with 
Dunn’s post-hoc procedure to identify differences. RESULTS: A total of 403 female 
subjects were recruited from 11 primary practices in 4 provinces, 60% of whom were 
employed and 63% had completed college; 22% were pre-menopausal, 33% were 
perimenopausal and 45% were post-menopausal. The mean 6-month cost was $261 
(SD  $586) for pre-menopause ($1.45/woman/day), $690 (SD  $2120) for perimeno-
pause ($3.83/woman/day) and $403 (SD  $797) for post-menopause ($2.24/woman/
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day). Overall, the cost was $466 (SD  $1361)/woman ($2.59/woman/day), with 
productivity loss accounting for 40% of the total, physician visits for 21% and medi-
cations for 11.6%. Statistically signiﬁcant differences were found between pre- and 
perimenopause (P  0.003) and between pre- and post-menopause (P  0.01). CON-
CLUSIONS: This observational study was based on data reported by women 48–54 
years of age, presenting at primary care practices in Canada. Perimenopause was the 
period with the highest burden. The major limitation was recall by subjects but the 
recall period was limited to a usually acceptable 6-month timeframe.
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OBJECTIVES: Pre-menstrual dysphoric disorder (PMDD) is a severe form of Pre-
menstrual Syndrome (PMS). Limited data exist to quantify the burden of PMDD on 
individual women and society, especially in a European setting. To investigate the 
relationship between symptom severity, cost and impairment in women with moder-
ate/severe PMS or PMDD. METHODS: A model was constructed to quantify costs 
and impairment, based on analysis of a cross-sectional dataset. Heterogeneity was 
assessed and data included from 9 OECD countries. Analyses were reported applying 
Swedish cost from a societal perspective to the cross-sectional dataset. Data were 
analysed according to categories of symptom severity based on the DRSP total luteal 
symptom score. Five severity categories were deﬁned: Category 1 comprised women 
with DRSP scores 21–41.9, Category 2, 42–62.9, Category 3, 63–83.9, Category 4, 
84–104.9, and Category 5 scores of 105. The output of the analysis was an estimate 
of mean annual cost and impact on quality of life (measured by utility) by category. 
Conﬁdence intervals were generated through non-parametric bootstrapping. 
RESULTS: A total of 756 women were included in the analysis, 225 provided data 
on quality of life. Total annual costs (direct and indirect) were estimated at: SEK 8894 
(95% CI 7137, 10,745), SEK 14,393 (95% CI 11,629, 17,505), SEK 24,178 (95% 
CI 17,961, 30,819), SEK 23,809 (95% CI 12,740, 40,144) and SEK 48,201 (95% CI 
26,103, 75,635) for categories 1 to 5 respectively; utility at 0.81 (95% CI 0.78, 0.84), 
0.72 (95% CI 0.67, 0.76), 0.71 (95% CI 0.64, 0.77), 0.63 (95% CI 0.47, 0.76) and 
0.78 (95% CI 0.70, 0.93). CONCLUSIONS: Our analysis, modeled from a Swedish 
societal perspective, found a substantial burden associated with moderate/severe PMS 
and PMDD increasing with severity of symptoms. Further quantiﬁcation of the mon-
etary impact and research into geographical interactions is needed to better understand 
the burden of PMDD.
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Walter E1, Brennig C1, Schöllbauer V2, Halwachs-Baumann G3
1IPF—Institute for Pharmaeconomic Research, Vienna, Austria, 2Institute for Pharmaeconomic 
Research, Vienna, Austria, 3Krankenhaus Steyr, Steyr, Austria
OBJECTIVES: Cytomegalovirus (CMV) can be transmitted to a developing child 
during pregnancy. In Germany, seropositivity rate is around 50%, risk of seroconver-
sion during pregnancy 1% and congenital infection resulting from primary infection 
about 50%. Every year 495 infants will be born with congenital CMV-syndrome and 
186 infants are infected but asymptomatic at birth and will develop a multitude of 
abnormalities (hearing loss, mental retardation etc.) due to primary CMV infection 
just as well as 750 children from seropositive mothers. The disease burden for affected 
children and parents is enormous. METHODS: The objective of this study was to 
estimate the total economic impact (lifetime direct and indirect costs based on deliver-
ies p.a.) on society due to CMV-infection based on incidences. Additionally this study 
shows the positive monetary impact of screening (serologic testing and treatment in 
case of primary infection). Direct costs comprise all treatment costs of symptoms 
appearing at birth or later on. The incidences of sequelae were derived from literature. 
Indirect costs comprise the changed job situation of parents, work absenteeism, 
nursing leave, lost human capital of dead people, costs of special schools and nursing 
homes. The resource use was determined by literature and experts. All costs represent 
data from 2008. RESULTS: The total discounted costs of CMV infection from a 
societal perspective were a243m p.a. (941ma undiscounted), whereas a225m p.a. 
(a870m undiscounted) are indirect costs corresponding to a766,444 per child (a2.97m 
undiscounted). Total costs for diagnosis and prevention are a50.43m. CMV screening 
and treatment of primary infected mothers by CMV speciﬁc hyperimmunoglobulin 
reduce total societal costs to a152ma (a444m undiscounted) and prevents infection in 
640 children. The budget impact amounts to a91m (a497m undiscounted). CONCLU-
SIONS: CMV-infection causes high disease burden and costs. A screening program is 
suitable to decrease future costs and disease burden of affected infants and parents.
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OBJECTIVES: Postmenopausal osteoporosis (PMO) increases the risk of fractures. 
However, studies have shown that only 20% of German osteoporosis patients receive 
osteoporosis-speciﬁc therapy and for many the adherence to medication is poor. This 
study assessed the economic burden of PMO in Germany. METHODS: We applied a 
systematic review of literature utilizing German based data to quantify osteoporosis-
related costs. Our analysis considered both direct costs (inpatient care with/without 
fracture, rehabilitation, medication, nursing care) and indirect costs (absence from 
work, early retirement and mortality) attributable to PMO. RESULTS: We identiﬁed 
and analyzed eight cost studies and two administrative databases published between 
1999 and 2009. Administrative data sources revealed annual direct and indirect costs 
of PMO amounting to a2205 million (direct costs: a1697–1879 million). Direct inpa-
tient costs resulting from osteoporosis-related fracture are three times higher than 
osteoporosis without fracture. Mean hip fracture costs were a7,109–a12,526 and 
mean costs of vertebral fractures were a4400–a6171. Ambulatory nursing care results 
in about a132 million per year. Annual inpatient rehabilitation costs add up to a147 
million. Annual costs of medication range between a338 million and a664 million. 
Annual indirect costs due to sickness absence were calculated at a146 million early 
retirement at a144 million and early death at a34 million. CONCLUSIONS: PMO 
currently has a considerable economic impact on the German health care system, 
which will increase with projected demographic changes. Strategies should be aimed 
at improving the management of this disease.
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COST-EFFECTIVENESS OF REDUCING MULTIPLE BIRTHS: IN-VITRO 
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OBJECTIVES: As the goals of in-vitro fertilization (IVF) treatments are to deliver a 
healthy child, where even a twin pregnancy is regarded as an adverse outcome, the 
economic impact of multiple births is an important policy consideration. METHODS: 
We estimated the potential cost savings by reducing the number of multiple pregnan-
cies and births in Canada over the next ﬁve years. The direct medical costs included 
clinical management costs of singleton, twin and higher order multiple (HOM) preg-
nancies, hospital delivery costs of mothers and their offspring by multiple birth, term 
and pre-term birth and the costs of disabilities due to pre-term/low weight birth. The 
analysis was conducted from the perspective of a third party payer in Canada. All 
parameters were based on recently published literature. The results were expressed as 
age-speciﬁc incremental costs per live birth. RESULTS: Given the reductions in mul-
tiple birth rate equivalent to those reached recently by selected European countries, 
we estimated that, over the next ﬁve years in Canada, the proportions of singletons, 
twins and HOM could be reduced from 71.2%, 27.5% and 1.3% to 86.6%, 12.8% 
and 0.6%, respectively. The potential cost savings are estimated to reach $266 million. 
The over-all incremental cost per live birth could be reduced by $15,228. For women 
under 35, aged 35–39, and over 40, the incremental cost reductions would be $17,023, 
$13,860 and $10,749, respectively. The bulk of cost reductions (over 70%) would be 
attributable to reductions in disability costs related with preterm/low weight births. 
Extensive sensitivity analysis has been provided. CONCLUSIONS: In the context of 
limited resources and ever-expanding need for health care services, prudent policies 
regarding multiple birth reductions are highly desirable.
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THE COST-EFFECTIVENESS OF ETONOGESTREL/ETHINYL ESTRADIOL 
VAGINAL RING IN SCOTLAND
Jensen JAG, Patel R, Mohlala BKF
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OBJECTIVES: With increasing numbers of termination of pregnancies in Scotland, 
offering a broader range of contraceptive options can increase the number of women 
satisﬁed with their method, leading to reduced discontinuation and the resulting posi-
tive consequences. This study aimed at assessing the cost-effectiveness of the etono-
gestrel (ENG)/ethinyl estradiol (EE) vaginal ring from the Scottish National Health 
Service (NHS) perspective. METHODS: A decision-analytic model was constructed to 
estimate the relative cost-effectiveness of the ENG/EE vaginal ring and a weighted, 
average second-line method (including the transdermal patch, long-acting methods, 
barrier and natural methods) following the use of oral contraceptives. Effectiveness 
data were derived from a systematic literature review and clinical trials for the vaginal 
ring. Costs were based on UK National sources. RESULTS: Versus a weighted, average 
second-line method, the vaginal ring cost an additional GBP£53 per woman and 
reduced the rate of unintended pregnancy by 0.0158. The incremental cost-effective-
ness ratio (ICER) of the vaginal ring versus a weighted, average second-line method 
was GBP£3337 per pregnancy averted. This ICER can be viewed as a conservative 
estimate as this study only assessed the weighted cost per pregnancy and was unable 
to address the psychological and physical implications which may result from an 
unintended pregnancy. Discontinuation and failure rates were a key determinant of 
the cost-effectiveness of the vaginal ring. CONCLUSIONS: Whilst the vaginal ring is 
more effective and more costly than a weighted, average second-line method from the 
Scottish NHS perspective, a lack of information surrounding indirect costs, compli-
ance impact and health state utilities warrants further analysis to determine the full 
cost implications. Collection of quality of life data for unintended pregnancies could 
assist in deriving an appropriate cost-effectiveness threshold.
